Anti-LCG monoclonal antibody (eXegenics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-LCG monoclonal antibody (eXegenics)
Drug Alias NameLung cancer gene - monoclonal antibody抗-LCG单克隆抗体（eXegenics）LCG monoclonal antibody (eXegenics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarepta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A